Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

AMPLIRUN® Coronavirus NL63 RNA PCR control

Products are for professional/laboratory use only.

New molecular control, now available!

We are pleased to announce the launch of the new Amplirun® that contains the purified RNA of coronavirus NL63 to be used as a control in nucleic acid amplification-based techniques.

Product code: MBC142-R
Product description: AMPLIRUN® CORONAVIRUS NL63 RNA CONTROL
Format: Lyophilized
Copies/µl: 12,500-20,000 once reconstituted

For Research Use Only (RUO)

  • Complete genome RNA control for coronavirus NL63, any target can be amplified
  • Allows validation of RTPCR assays
  • Precise concentration in copies/µl verified by Digital Droplet PCR (ddPCR)
  • Non-infectious material with inactivation certificate
  • Independent third-party control valid for any molecular testing platform        

Request insert sheet here →

See full list of all Amplirun® controls available

Download Brochure >

Read more on Vircell DNA-RNA Amplification Controls

Click Here >



Request a Quote

Request Quote

Recent Posts

Certest – VIASURE Pneumocystis jirovecii Real Time PCR Detection Kit

Pneumocystis jirovecii can cause Pneumocystis pneumonia (PCP), a life-threatening infection, especially in immunocompromised individuals such as those with HIV/AIDS, cancer patients, and organ transplant recipients….

Read full article

Biosignatures in Adult Patients with Sepsis—Critical Care Explorations (CCE), Highlighting SeptiCyte Rapid

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.We are excited to share that SeptiCyte® RAPID has been featured in the publication “The…

Read full article

Vircell 2026 Catalogues – Molecular Biology & Infectious Immunology

Vircell 2026 Catalogues* Infectious Immunology | Molecular Biology – Diagnostic Solutions for Human Infectious Diseases Discover the latest molecular biology and infectious immunology advancements with…

Read full article